Diagenode

>>>   Click for Diagenode’s approach to COVID-19

CRISPR/Cas9 antibodies

RNA-targeting CRISPR antibodies

The latest tool for CRISPR gene editing is a new CRISPR-C2C2 (Cas13a) system which utilizes RNA-guided RNA-targeting for RNA knockdown and binding in cells. C2C2 (Cas13a) may be useful for isolating specific RNA sequences or even studying single RNA molecules with high specificity. Unlike editing DNA as with Cas9 which makes permanent genomic changes,  targeting RNA with C2C2 allows temporarily altering the amount of protein potentially offering a better therapeutic approach in the future. 

Use Diagenode's new C2C2 (Cas13a) polyclonal antibody to determine precision and success metrics in CRISPR experiments.

Products

Cat. No.ProductApplicationPurity
C15200249 C2C2 monoclonal antibody
(50 µg/50 µl)
WB Protein G purified monoclonal antibody
C15310267-100 C2C2 polyclonal antibody
(100 μl)
WB Whole antiserum from rabbit containing 0.05% azide.
C15100149 LwaCas13a Antibody
(100 µl)
WB Concentrated cell culture supernatant.
C15200250 PspCas13b monoclonal antibody
(50 µg)
WB Protein G purified monoclonal antibody.

Events

  • DNA methylation workshop: Become an expert at RRBS
    Diagenode
    Oct 1-Oct 31, 2021
  • Dutch Chromatin Meeting
    Radboud UMC, Geert Grooteplein 15, 6525 EZ Nijmegen, The Netherlands, Experience center, route 292 to 307
    Nov 12, 2021
 See all events

News

 See all news


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.



  ABOUT SSL CERTIFICATES

       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics